JPMorgan's Bullish Outlook on Wells Fargo Stock Ahead of Q2 Earnings
Money

JPMorgan's Bullish Outlook on Wells Fargo Stock Ahead of Q2 Earnings

authorBy Vicki Robin
DateJul 13, 2026
Read Time3 min

JPMorgan Chase has recently offered an optimistic assessment of Wells Fargo & Co's stock performance, elevating its price target in anticipation of robust second-quarter earnings. This positive outlook is underpinned by projections of significant revenue and earnings per share growth, fueled by strong consumer and business activity, which directly translates to expanding loan portfolios and deposit bases for the banking institution.

JPMorgan Bolsters Price Target for Wells Fargo Amidst Strong Q2 Projections

In a noteworthy development on July 6, 2026, the prominent financial institution JPMorgan Chase & Co. revised its price target for Wells Fargo & Co (NYSE:WFC) shares, moving it upwards from $86.50 to $93.50. Despite this bullish adjustment in valuation, JPMorgan opted to sustain a 'Neutral' rating on the stock. This re-evaluation by JPMorgan's analysts formed part of their comprehensive preview of the second-quarter 2026 earnings for major large-cap banks, signaling a positive trajectory for Wells Fargo.

Wells Fargo, a multinational banking and financial services behemoth, is slated to disclose its second-quarter financial outcomes on July 14, 2026. Market analysts are collectively forecasting an encouraging 4.9% year-over-year surge in the bank's revenue, expected to reach an impressive $21.8 billion. This projected growth is largely attributed to the sustained expansion in both consumer and business expenditure, which has been a driving force behind increased loan volumes and deposits. Furthermore, the bank's GAAP earnings per share (EPS) are predicted to climb by 7%, arriving at $1.71, a gain expected to be fortified by the institution's stringent cost management strategies aimed at enhancing operational profit margins. Earlier in June, during an investor conference, Wells Fargo had already indicated that its loan growth was surpassing initial expectations, reinforcing the positive sentiment surrounding its upcoming earnings report.

JPMorgan's upgraded price target, even with a 'Neutral' stance, reflects a cautious yet confident view on Wells Fargo's near-term financial health and operational efficiency. The market will be closely watching the actual Q2 results to see if they align with these promising forecasts, potentially cementing Wells Fargo's position as a resilient player in the current economic landscape.

The recent positive re-evaluation of Wells Fargo by JPMorgan provides valuable insights into the dynamic banking sector. It underscores the importance of robust consumer and business spending in driving financial growth, even for established giants. As investors navigate evolving market conditions, such analyses serve as crucial indicators, highlighting the ongoing impact of fundamental economic activities on corporate performance. While the banking sector presents its own unique set of opportunities and challenges, the focus on cost discipline and organic growth through increased loan volumes remains a core strategy for sustained success.

More Articles
Money
Jefferies and Citi Adjust Price Targets for Leidos (LDOS)
Jefferies and Citi have recently updated their price targets for Leidos Holdings, Inc. (LDOS). Jefferies reduced its target from $140 to $110, maintaining a 'Hold' rating, anticipating fiscal Q2 2026 earnings to be the year's lowest point due to a projected decline in the Health unit. Citi, on the other hand, lowered its target from $178 to $138 but kept a 'Buy' rating, as part of a broader review of the aerospace and defense sector, expecting stronger performance from aerospace companies.
By Scott PapeJul 13, 2026
Money
Taiwan Semiconductor Manufacturing Reports Strong June Sales
Taiwan Semiconductor Manufacturing (TSM) announced impressive June sales figures, exceeding analyst expectations. The leading contract chipmaker saw a substantial 67.9% year-over-year increase in sales, reaching nearly 443 billion New Taiwan dollars ($13.99 billion). This positive news caused TSM stock to fluctuate in early trading.
By Natalie PaceJul 13, 2026
Money
Nuvation Bio Stock: A Look at Its Growth Prospects and Drug Development
Nuvation Bio Inc. (NUVB) has seen significant stock gains, with analysts predicting further upside. The company is actively expanding the market for its lung cancer drug, taletrectinib, which targets advanced ROS1-positive non-small cell lung cancer. With existing approvals in the US, Japan, and China, Nuvation Bio is now seeking approval in the UK and other international markets, demonstrating its global expansion strategy while maintaining a strong financial position.
By Scott PapeJul 13, 2026
Money
Optimistic Outlook for Intuitive Machines (LUNR) Amidst Recent Stock Dip
Despite a recent 40% stock price decline, analysts from Craig-Hallum and B. Riley maintain a 'Buy' rating on Intuitive Machines (LUNR). The company recently secured a $148 million NASA lunar lander contract, reinforcing its position in the space technology sector. Experts view the current market weakness as a buying opportunity, citing a strong order backlog and promising future catalysts.
By Mr. Money MustacheJul 13, 2026
Money
Nubank to inject $4.2 billion into Mexican market expansion
Nubank (Nu Holdings Ltd.) is set to invest $4.2 billion in Mexico over the next four years, aiming to expand its digital banking services. This move follows the company's recent license acquisition, allowing for broader lending and deposit offerings. With a strong customer base across Latin America, particularly in Brazil, Mexico, and Colombia, Nubank seeks to further strengthen its presence in the region, focusing on operational growth and new banking product rollouts.
By Ramit SethiJul 13, 2026